BBLG Bone Biologics Corporation Stock Quote

BBLG [NASD]

Index	-	P/E	-	EPS (ttm)	-0.53	Insider Own	70.04%	Shs Outstand	10.35M	Perf Week	20.15%
Market Cap	15.63M	Forward P/E	-	EPS next Y	-0.83	Insider Trans	0.00%	Shs Float	3.13M	Perf Month	-28.44%
Income	-1.60M	PEG	-	EPS next Q	-0.17	Inst Own	0.40%	Short Float	1.20%	Perf Quarter	-24.77%
Sales	-	P/S	-	EPS this Y	43.40%	Inst Trans	-	Short Ratio	0.13	Perf Half Y	-58.40%
Book/sh	-1.23	P/B	-	EPS next Y	-25.80%	ROA	-	Target Price	8.00	Perf Year	-97.78%
Cash/sh	0.60	P/C	2.70	EPS next 5Y	-	ROE	-	52W Range	1.16 - 7.12	Perf YTD	-54.26%
Dividend	-	P/FCF	-	EPS past 5Y	54.00%	ROI	-	52W High	-77.39%	Beta	-
Dividend %	-	Quick Ratio	-	Sales past 5Y	-	Gross Margin	-	52W Low	38.79%	ATR	0.25
Employees	2	Current Ratio	-	Sales Q/Q	-	Oper. Margin	-	RSI (14)	40.85	Volatility	13.71% 15.71%
Optionable	No	Debt/Eq	-	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.09	Prev Close	1.58
Shortable	Yes	LT Debt/Eq	-	Earnings	-	Payout	-	Avg Volume	298.01K	Price	1.61
Recom	-	SMA20	-14.42%	SMA50	-28.29%	SMA200	-87.44%	Volume	27,302	Change	1.90%

Mar-23-22 08:00AM	Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest Business Wire +5.35%
Mar-18-22 07:25AM	We're Hopeful That Bone Biologics (NASDAQ:BBLG) Will Use Its Cash Wisely Simply Wall St. +26.27%
07:15AM	BBLG: Bone Biologics Inks Important Supply Agreement Zacks Small Cap Research
Mar-07-22 07:00AM	Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix Business Wire -6.25%
Feb-24-22 06:00AM	BBLG: Back Pain Solution Potentially on the Way Zacks Small Cap Research -6.31%
Jan-10-22 03:50PM	BBLG Stock Alert: 7 Things to Know as Bone Biologics Skyrockets Today InvestorPlace +57.14%
10:38AM	Why Are Bone Biologics Shares Surging On Monday? Benzinga
Jan-05-22 08:30AM	Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference Business Wire
Nov-17-21 06:43AM	25 Stocks Moving in Wednesday's Pre-Market Session Benzinga
Nov-16-21 06:49AM	36 Stocks Moving in Tuesday's Pre-Market Session Benzinga
Nov-10-21 09:15AM	BBLG: Bone Biologics Zacks Small Cap Research
Nov-02-21 07:26AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday InvestorPlace
07:04AM	24 Stocks Moving in Tuesday's Pre-Market Session Benzinga
Oct-18-21 08:30AM	Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq Business Wire
Oct-15-21 12:00PM	WallachBeth Capital Announces Completion of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering PR Newswire
Oct-13-21 01:43PM	WallachBeth Capital announces pricing of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering and Uplisting to the NASDAQ Capital Market PR Newswire -72.85%
12:25PM	Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Reverse Stock Split Business Wire

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience